These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30938828)

  • 41. Thalidomide as a potential treatment for scleromyxedema.
    Caradonna S; Jacobe H
    Arch Dermatol; 2004 Mar; 140(3):277-80. PubMed ID: 15023770
    [No Abstract]   [Full Text] [Related]  

  • 42. Minimal change nephropathy in a 7-year-old boy with Rosai-Dorfman disease.
    Sakallioglu O; Gok F; Kalman S; Atay AA; Kaya A; Duzova A; Gokcay E
    J Nephrol; 2006; 19(2):211-4. PubMed ID: 16736423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to methotrexate and mercaptopurine.
    Horneff G; Jürgens H; Hort W; Karitzky D; Göbel U
    Med Pediatr Oncol; 1996 Sep; 27(3):187-92. PubMed ID: 8699998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rosaceiform dermatitis associated with topical tacrolimus treatment.
    Fujiwara S; Okubo Y; Irisawa R; Tsuboi R
    J Am Acad Dermatol; 2010 Jun; 62(6):1050-2. PubMed ID: 20466178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Photodynamic therapy in lupus miliaris disseminatus faciei's scars.
    Borgia F; Giuffrida R; Vaccaro M; Lentini M; Cannavò SP
    Dermatol Ther; 2016 Sep; 29(5):320-324. PubMed ID: 27356779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutaneous Rosai-Dorfman Disease.
    Keeling BH; Thelin LL; Gavino AC; Ahmed AM
    Skinmed; 2017; 15(4):301-302. PubMed ID: 28859745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Superficial granulomatous pyoderma gangrenosum of the face, successfully treated by ciclosporine: a long-term follow-up.
    Lachapelle JM; Marot L; Jablonska S
    Dermatology; 2001; 202(2):155-7. PubMed ID: 11306846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extensive purely cutaneous Rosai-Dorfman disease responsive to acitretin.
    Mebazaa A; Trabelsi S; Denguezli M; Sriha B; Belajouza C; Nouira R
    Int J Dermatol; 2007 Nov; 46(11):1208-10. PubMed ID: 17988346
    [No Abstract]   [Full Text] [Related]  

  • 49. Image Gallery: Metachronic occurrence of primary cutaneous marginal zone B-cell lymphoma and primary cutaneous Rosai-Dorfman disease in the same patient.
    González-Quesada A; Bastida J; Rivero-Vera JC; Piris-Pinilla MA; Limeres-González MA
    Br J Dermatol; 2017 Dec; 177(6):e355. PubMed ID: 29313941
    [No Abstract]   [Full Text] [Related]  

  • 50. A combination of oral azathioprine and methotrexate in difficult to treat dermatoses.
    Agarwal P; Agarwal US; Meena RS; Sharma P
    Indian J Dermatol Venereol Leprol; 2017; 83(3):389-392. PubMed ID: 28366928
    [No Abstract]   [Full Text] [Related]  

  • 51. A Woman with Red Edematous Erythema of the Face: A Quiz.
    Zhang HY; Li ZX
    Acta Derm Venereol; 2024 Aug; 104():adv40766. PubMed ID: 39113340
    [No Abstract]   [Full Text] [Related]  

  • 52. Multiple Papules and Nodules Over the Body with Diffuse Thickening of the Facial Skin: A Quiz.
    Reddy A; Buccha Y; Manoj R; Puttur N; Lakhey K
    Acta Derm Venereol; 2024 Jul; 104():adv40206. PubMed ID: 39007460
    [No Abstract]   [Full Text] [Related]  

  • 53. A case report demonstrating potential utility of topical imiquimod for cutaneous Rosai-Dorfman disease.
    Karadag AS; Tekin B; Hurdogan O; Dagdelen D; Dogan O; Buyukbabani N
    Dermatol Ther; 2019 Jan; 32(1):e12759. PubMed ID: 30288863
    [No Abstract]   [Full Text] [Related]  

  • 54. Aggressive giant keratoacanthoma of the face treated with intramuscular methotrexate and triamcinolone acetonide.
    Santoso-Pham JC; Shelley ED; Shelley WB
    Cutis; 1997 Jun; 59(6):329-32. PubMed ID: 9218892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical cyclosporine treatment in inflammatory nodular acne.
    Ciftci S
    Eur J Dermatol; 2008; 18(6):716-7. PubMed ID: 19049938
    [No Abstract]   [Full Text] [Related]  

  • 56. Sinus histiocytosis with massive lymphadenopathy: a case with facial bones involvement.
    Günhan O; Finci R; Günaydin Y; Somuncu I
    J Oral Maxillofac Surg; 1991 Feb; 49(2):205-9. PubMed ID: 1990100
    [No Abstract]   [Full Text] [Related]  

  • 57. Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).
    Pagel JM; Lionberger J; Gopal AK; Sabath DE; Loeb K
    Am J Hematol; 2007 Dec; 82(12):1121-2. PubMed ID: 17696200
    [No Abstract]   [Full Text] [Related]  

  • 58. What factors affect the duration of treatment with diphenylcyclopropenone immunotherapy for common warts?
    Seo HM; Park HK; Kim TL; Kim JS
    Dermatol Ther; 2018 Nov; 31(6):e12740. PubMed ID: 30203625
    [No Abstract]   [Full Text] [Related]  

  • 59. Benign cephalic histiocytosis: a case report and review.
    Jih DM; Salcedo SL; Jaworsky C
    J Am Acad Dermatol; 2002 Dec; 47(6):908-13. PubMed ID: 12451377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of histiocytic lymphophagocytic panniculitis (Rosai-Dorfman disease) with positive autoantibodies.
    Wang F; Chen X; Wu W; Wang Z; Han J
    J Dtsch Dermatol Ges; 2015 Apr; 13(4):334-6. PubMed ID: 25819246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.